Iceland’s digital medical-record requirement takes effect on 1 December 2026, but the Directorate of Health says it does not approve individual record systems or maintain an approved-system register. The provider acting as controller remains responsible for selecting and assessing a suitable system. The authority’s new documents support that assessment. Directorate notice
The guidance also says the Directorate must be notified which system is used. Notification and individual product approval are distinct steps. Official guidance
For a small practice, the distinction is practical: a digital deadline creates a recordkeeping requirement, while choosing a supplier still requires a reasoned assessment of the actual service being purchased.
The December date belongs to specified legal provisions
Act No. 81/2025 amends Iceland’s Medical Records Act No. 55/2009. Article 3 introduces the relevant digital-system wording; Article 13 gives specified provisions a commencement date of 1 December 2026. It would be inaccurate to describe every part of the 2025 amendment as first taking effect that day. Official Icelandic amendment
The Directorate’s 11 November notice supplies an accessible explanation of the upcoming recordkeeping change. Its English version is automatically translated; the original law and Icelandic guidance remain important when precise wording matters.
A checklist replaces neither responsibility nor evidence
The Directorate supplies a 39-question checklist across eight categories. These cover the system and supplier, hosting, contracts and exit, access, traceability, security, continuity and patient rights. The supporting guidance is dated 3 November 2026. Official document collection · Guidance PDF
The tool asks providers to obtain answers and evidence about the relevant product version and service. An unclear answer calls for assessment and documentation, rather than becoming an automatic pass. The checklist also anticipates reviewing evidence when relevant arrangements change. Checklist PDF
Five useful questions to take into a supplier conversation
The following are our plain-language groupings of the official assessment topics, not a replacement checklist or a scoring system.
| Question | Evidence to locate in the proposed arrangement |
|---|---|
| Which exact service is being assessed? | Product version, supplier responsibilities and the hosting arrangement. |
| Who can see or change a record? | Access arrangements and the ability to trace relevant activity. |
| What happens when service is interrupted? | Continuity and incident arrangements for the proposed service. |
| What happens when the contract ends? | Contractual provisions for access, transfer and exit. |
| How are patient rights supported? | The relevant processes and responsibilities, with supporting documentation. |
These questions translate the checklist’s subject areas into a conversation about the service. They do not establish that any answer is sufficient for a particular provider. Underlying official checklist
Templates help document the work
The official collection includes four templates: a security manual, risk assessment, annual internal-control summary and deviation log. The guidance presents supporting templates as aids; equivalent documentation can be used. It also addresses small providers, including individual practitioners. Templates and supporting material · Guidance
A blank template and a completed assessment have different evidential value. The latter should explain the actual arrangement and the reasoning behind it. Similarly, a supplier’s general security statement does not establish the details of every customer’s hosting, contract or access configuration.
Keep the jurisdiction and purpose visible
Our English digital-health assessment explainer addresses a different framework. Its categories or assessment outcome cannot be transferred into an Icelandic product approval that the Directorate says it does not provide.
The supported administrative message is specific: prepare for the digital-record requirement, use the authority’s materials to examine the proposed system, and retain the provider’s responsibility for the selection. This article does not assess an individual product’s compliance or a practice’s readiness.
